Table of Content

1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Luxturna (voretigene neparvovec-rzyl)
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options



List of Figures


Figure 1 The Development Timeline of Luxturna (voretigene neparvovec-rzyl)
Figure 2 Patent Details, Luxturna (voretigene neparvovec-rzyl)
Figure 3 Luxturna (voretigene neparvovec-rzyl), 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Luxturna (voretigene neparvovec-rzyl), US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Luxturna (voretigene neparvovec-rzyl), EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Luxturna (voretigene neparvovec-rzyl), EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Luxturna (voretigene neparvovec-rzyl), Japan Market Size from 2017 to 2030 (in Millions USD)


List of Tables


Table 1 Luxturna (voretigene neparvovec-rzyl), Description
Table 2 Luxturna (voretigene neparvovec-rzyl), Trial Diversification
Table 3 Luxturna (voretigene neparvovec-rzyl), Marketed Details United States
Table 4 Luxturna (voretigene neparvovec-rzyl), Marketed Details Europe
Table 5 Luxturna (voretigene neparvovec-rzyl), Marketed Details Japan
Table 6 Patent Details: Luxturna (voretigene neparvovec-rzyl)
Table 7 Luxturna (voretigene neparvovec-rzyl), Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Luxturna (voretigene neparvovec-rzyl)
Table 9 Luxturna (voretigene neparvovec-rzyl), 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Luxturna (voretigene neparvovec-rzyl), US Market Size from 2017 to 2030 (in Million USD)
Table 11 Luxturna (voretigene neparvovec-rzyl), EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Luxturna (voretigene neparvovec-rzyl), EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Luxturna (voretigene neparvovec-rzyl), Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies